What's next in dementia research?



Every three seconds someone is diagnosed with dementia. It’s a disease that will most likely affect the life of someone we know at some point in our lifetime.

Our achievements in dementia research

The Queensland Brain Institute is home to the Clem Jones Centre for Ageing and Dementia Research (CJCADR) who celebrate 10 years of excellence in dementia research this year.

Over these last 10 years we have made breakthrough discoveries that have the potential to drive treatments and interventions for dementia, including:

Associate Professor Victor Anggono (left) is working on discovery research that could improve the lives of people living with dementia.

The next 10 years in dementia research at QBI

Looking forward to the next 10 years, our team at CJCADR will continue to bring strengths from all aspects of neuroscience and cutting-edge technology to:

  • understand the changes that occur within the brain in dementia
  • develop new technologies, tools and biomarkers
  • design new treatments and preventive approaches. 

Discovery research

Discovery research is vital to understanding dementia. It explores possibilities that lead to tomorrow's health solutions. 

Our dementia discovery research over the 10 ten years will include:

  • Investigating the role of fatty acids in memory formation and the potential for supplements to support the ageing brain.
  • Exploring the role of dietary selenium intake on neurogenesis.
  • Identifying the exercise ‘sweet spot’ to support cognitive function in older age.
  • Investigating the role of inflammation in dementia – including the role of inflammasomes - as a potential therapeutic target for Alzheimer’s disease.
  • Illuminating molecular structures that facilitate communication between healthy brain cells – and which break down in dementia - to identify potential treatment targets.
  • Investigating the processes driving new brain cell production in the adult brain and the impacts of exercise.
Dr Dan Blackmore (left)  is investigating the exercise sweet spot to support cognitive function in older age.


Clinical research connects the science with patients to look at dementia as broadly as possible. Some of our upcoming clinical projects are:

  • Advancing diagnostics to better differentiate between the types of dementia – for more accurate and timely diagnosis.
  • Developing tools to enable early diagnosis and early access to interventions for dementia.
Professor Gail Robinson (left) is one of the QBI clinicians developing tools to enable early diagnosis and early access to interventions for dementia.


From bench to bedside (translational research)

Translational research is when it moves from the bench to the bedside. It translates research discoveries into applications that can directly improve human health. Some of our promising translational projects include:

  • Developing antibodies as potential dementia therapies.
  • Developing therapeutic ultrasound as a highly promising therapy for dementia and other brain disorders.
Professor Jürgen Götz with the UltraTheraPilot trial-ready medical device that was developed and fabricated at QBI.


Give to dementia research 


Keep up to date with QBI research news and events



The Brain: Dementia QBI


Last updated:
20 October 2022